http://www.rivervest.com/ 2012-01-10T17:07:12+00:00 daily 1.0 http://www.rivervest.com/case-studies/case-study-2/ 2012-02-01T16:56:27+00:00 weekly 0.6 http://www.rivervest.com/team/john-mckearn/ 2012-02-01T16:48:45+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/john-mckearn-phd/ 2012-02-01T16:45:26+00:00 weekly 0.6 http://www.rivervest.com/case-studies/case-study-3/ 2012-02-01T16:43:47+00:00 weekly 0.6 http://www.rivervest.com/home/home-page-case-study-3/ 2012-02-01T16:15:59+00:00 weekly 0.6 http://www.rivervest.com/portfolio/ 2012-02-01T16:13:26+00:00 weekly 0.6 http://www.rivervest.com/mobile/portfolio-2/ 2012-02-01T16:09:14+00:00 weekly 0.6 http://www.rivervest.com/case-studies/case-study-1/ 2012-02-01T15:46:35+00:00 weekly 0.6 http://www.rivervest.com/case-studies/ 2012-02-01T15:34:40+00:00 weekly 0.6 http://www.rivervest.com/home/home-page-case-study-1/ 2012-02-01T15:33:28+00:00 weekly 0.6 http://www.rivervest.com/team/karen-spilizewski/ 2012-02-01T15:16:37+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/karen-spilizewski/ 2012-02-01T15:15:02+00:00 weekly 0.6 http://www.rivervest.com/team/niall-odonnell/ 2012-02-01T15:04:05+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/niall-odonnell-phd/ 2012-02-01T15:01:46+00:00 weekly 0.6 http://www.rivervest.com/team/thomas-c-melzer/ 2012-02-01T14:56:55+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/thomas-c-melzer/ 2012-02-01T14:40:19+00:00 weekly 0.6 http://www.rivervest.com/team/jay-schmelter/ 2012-02-01T14:30:29+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/jay-w-schmelter/ 2012-02-01T14:26:41+00:00 weekly 0.6 http://www.rivervest.com/bard-acquires-lutonix-inc/ 2012-01-10T17:07:12+00:00 monthly 0.2 http://www.rivervest.com/pfizer-to-acquire-excaliard-pharmaceuticals/ 2011-11-22T13:50:24+00:00 monthly 0.2 http://www.rivervest.com/3000-patient-meta-analysis-reinforces-importance-of-platelet-reactivity-testing-to-aid-in-risk-assessment/ 2011-11-08T17:56:03+00:00 monthly 0.2 http://www.rivervest.com/new-data-underscores-importance-of-platelet-reactivity-testing-to-aid-in-risk-assessment/ 2011-10-11T16:09:12+00:00 monthly 0.2 http://www.rivervest.com/jumpstart-and-rivervest-invest-in-medical-device-firm-company-relocates-to-cleveland-from-boston/ 2011-10-11T16:08:23+00:00 monthly 0.2 http://www.rivervest.com/otonomy-presents-positive-new-findings-from-phase-1b-study-of-oto-104-in-meniere%e2%80%99s-disease-at-international-conference/ 2011-09-29T16:51:16+00:00 monthly 0.2 http://www.rivervest.com/varian-medical-systems-signs-agreement-to-acquire-calypso-medical-technologies-acquisition-adds-products-for-tracking-tumor-motion-during-radiosurgery-and-radiotherapy/ 2011-09-28T13:38:46+00:00 monthly 0.2 http://www.rivervest.com/platelet-reactivity-testing-included-in-2011-guideline-recommendations-from-european-society-of-cardiology/ 2011-09-22T13:04:11+00:00 monthly 0.2 http://www.rivervest.com/university-hospitals-and-centerre-healthcare-announce-joint-venture-to-open-comprehensive-inpatient-rehabilitation-hospital/ 2011-08-29T14:14:00+00:00 monthly 0.2 http://www.rivervest.com/centerre-healthcare-corporation-and-mercy-health-center-announce-new-rehab-hospital/ 2011-08-29T14:09:12+00:00 monthly 0.2 http://www.rivervest.com/idev-technologies-announces-completion-of-superb-clinical-trial-enrollment/ 2011-08-03T15:35:56+00:00 monthly 0.2 http://www.rivervest.com/texas-rehabilitation-hospital-brings-inpatient-traumatic-brain-injury-spinal-cord-rehabilitation-to-tarrant-county/ 2011-07-28T12:53:56+00:00 monthly 0.2 http://www.rivervest.com/idev-technologies-launches-lower-profile-supera-veritas%c2%ae-stent-delivery-system/ 2011-07-28T12:31:12+00:00 monthly 0.2 http://www.rivervest.com/first-patient-enrolled-in-lutonix-drug-coated-balloon-pivotal-trial/ 2011-07-26T13:48:09+00:00 monthly 0.2 http://www.rivervest.com/team/ 2011-07-18T19:18:23+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/ 2011-07-18T19:14:54+00:00 weekly 0.6 http://www.rivervest.com/medtronic-to-acquire-salient-surgical-technologies-inc/ 2011-07-13T13:37:37+00:00 monthly 0.2 http://www.rivervest.com/new-ce-marked-prognostic-claim-for-the-verifynow-p2y12-test/ 2011-05-20T20:00:30+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-signs-national-distribution-agreement-with-cardinal-health/ 2011-05-11T17:59:46+00:00 monthly 0.2 http://www.rivervest.com/john-mckearn-ph-d-promoted-to-managing-director-of-rivervest-venture-partners/ 2011-05-03T13:25:50+00:00 monthly 0.2 http://www.rivervest.com/case-studies/venturing-into-the-ear-frontier/ 2011-05-03T02:16:54+00:00 weekly 0.6 http://www.rivervest.com/home/home-page-case-study-4/ 2011-05-03T02:15:37+00:00 weekly 0.6 http://www.rivervest.com/2011-accfaha-guidelines-incorporate-new-recommendation-for-platelet-reactivity-testing/ 2011-04-28T19:11:21+00:00 monthly 0.2 http://www.rivervest.com/otonomy-announces-positive-results-from-phase-1b-study-of-oto-104-in-meniere%e2%80%99s-disease/ 2011-04-28T18:58:03+00:00 monthly 0.2 http://www.rivervest.com/mpex-pharmaceuticals-inc-to-be-acquired-by-axcan/ 2011-04-15T15:25:02+00:00 monthly 0.2 http://www.rivervest.com/team/andrew-b-craig-iii/ 2011-04-04T14:07:52+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/andy/ 2011-04-04T14:06:02+00:00 weekly 0.6 http://www.rivervest.com/2011-surgical-guidelines-recommend-point-of-care-platelet-reactivity-testing-prior-to-surgery/ 2011-03-09T20:34:01+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-signs-development-supply-agreement-with-portola-pharmaceuticals-inc/ 2011-03-07T15:06:24+00:00 monthly 0.2 http://www.rivervest.com/ligand-acquires-cydex-pharmaceuticals/ 2011-01-27T15:50:06+00:00 monthly 0.2 http://www.rivervest.com/mpex-initiates-phase-3-clinical-trial-program-with-aeroquintm-for-the-treatment-of-chronic-bacterial-infections-in-cystic-fibrosis-patients/ 2011-01-24T19:53:10+00:00 monthly 0.2 http://www.rivervest.com/excaliard-announces-positive-results-from-three-phase-2-clinical-trials-for-exc-001-showing-significant-improvement-in-both-hypertrophic-and-fine-line-scarring/ 2011-01-10T21:42:27+00:00 monthly 0.2 http://www.rivervest.com/contact-us/rivervest-newsletter/ 2011-01-04T19:12:49+00:00 weekly 0.6 http://www.rivervest.com/contact-us/newsletter-sign-up/ 2011-01-04T18:36:42+00:00 weekly 0.6 http://www.rivervest.com/icad-to-acquire-xoft-inc/ 2010-12-17T20:25:53+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-closes-2010-with-positive-outlook/ 2010-12-10T17:21:31+00:00 monthly 0.2 http://www.rivervest.com/otonomy-appoints-david-a-weber-ph-d-chief-executive-officer/ 2010-12-09T13:24:53+00:00 monthly 0.2 http://www.rivervest.com/about-us/ 2010-11-30T14:33:48+00:00 weekly 0.6 http://www.rivervest.com/mobile/about/ 2010-11-30T14:33:13+00:00 weekly 0.6 http://www.rivervest.com/gravitas-trial-shows-that-a-uniform-treatment-strategy-of-doubling-the-standard-dose-of-plavix-does-not-improve-outcomes-post-pci/ 2010-11-16T16:27:24+00:00 monthly 0.2 http://www.rivervest.com/idev-technologies-announces-fda-510k-clearance-for-supera-veritas%e2%84%a2/ 2010-11-03T15:57:53+00:00 monthly 0.2 http://www.rivervest.com/macrogenics-enters-global-research-collaboration-and-license-agreement-with-pfizer/ 2010-10-28T18:37:38+00:00 monthly 0.2 http://www.rivervest.com/boehringer-ingelheim-and-macrogenics-announce-global-alliance-to-discover-develop-and-commercialize-dart%e2%84%a2-based-antibody-therapeutics/ 2010-10-26T14:38:42+00:00 monthly 0.2 http://www.rivervest.com/cydex-pharmaceuticals-obtains-full-development-and-commercialization-rights-to-novel-captisol-enabled%c2%ae-intravenous-formulation-of-clopidogrel/ 2010-10-26T14:17:21+00:00 monthly 0.2 http://www.rivervest.com/excaliard-pharmaceuticals-appoints-thomas-wiggans-to-chairman-of-the-board/ 2010-10-18T19:30:17+00:00 monthly 0.2 http://www.rivervest.com/idev-technologies-completes-46-million-preferred-stock-financing-with-piper-jaffray-and-additional-strategic-investor/ 2010-10-14T16:19:54+00:00 monthly 0.2 http://www.rivervest.com/calypso-medical-receives-fda-510k-clearance-for-dynamic-edge-gating-technology/ 2010-10-14T16:14:18+00:00 monthly 0.2 http://www.rivervest.com/tryton-completes-20-million-financing-to-accelerate-u-s-pivotal-trial/ 2010-09-16T16:39:29+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-increases-capital-raise-completes-final-close-in-24-million-capital-financing/ 2010-09-01T15:33:20+00:00 monthly 0.2 http://www.rivervest.com/otonomy-closes-38-5-million-series-b-financing/ 2010-08-31T13:42:20+00:00 monthly 0.2 http://www.rivervest.com/idev-technologies-enters-into-an-exclusive-distribution-agreement-with-trireme-medical/ 2010-07-21T18:28:32+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-inc-daiichi-sankyo-inc-and-eli-lilly-and-company-launch-strategic-u-s-collaboration/ 2010-07-13T19:16:13+00:00 monthly 0.2 http://www.rivervest.com/gilead-sciences-to-acquire-cgi-pharmaceuticals-for-up-to-120-million/ 2010-06-25T15:07:58+00:00 monthly 0.2 http://www.rivervest.com/idev-technologies-announces-european-launch-of-supera-veritas%e2%84%a2-stent-delivery-system/ 2010-05-26T14:06:18+00:00 monthly 0.2 http://www.rivervest.com/idev-technologies-names-veteran-healthcare-executive-dennis-donohoe-m-d-chief-medical-officer/ 2010-05-24T18:39:18+00:00 monthly 0.2 http://www.rivervest.com/mpex-pharmaceuticals-presents-positive-phase-2-clinical-trial-results-of-aeroquin%e2%84%a2-mp-376-treatment-in-cystic-fibrosis-patients/ 2010-05-18T13:38:10+00:00 monthly 0.2 http://www.rivervest.com/research-published-in-the-new-england-journal-of-medicine-highlights-potential-benefits-of-cameron-health%e2%80%99s-s-icd-system-the-first-minimally-invasive-implantable-defibrillator-for-the-treatme/ 2010-05-18T13:30:06+00:00 monthly 0.2 http://www.rivervest.com/texas-health-fort-worth-and-centerre-healthcare-corporation-to-open-inpatient-rehabilitation-facility/ 2010-04-30T20:00:04+00:00 monthly 0.2 http://www.rivervest.com/cydex-pharmaceuticals-initiates-dosing-for-phase-2a-oncology-drug-trial/ 2010-04-30T19:31:59+00:00 monthly 0.2 http://www.rivervest.com/inadequate-response-to-clopidogrel-leads-to-higher-incidence-of-major-adverse-cardiac-events-in-patients-who-have-undergone-pci/ 2010-04-06T18:58:10+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-inc-announces-completion-of-gravitas-trial-enrollment/ 2010-04-06T18:39:59+00:00 monthly 0.2 http://www.rivervest.com/rivervest-venture-partners-promotes-niall-o%e2%80%99donnell-ph-d-to-principal/ 2010-04-01T13:04:16+00:00 monthly 0.2 http://www.rivervest.com/cameron-health-inc-appoints-kevin-hykes-president-and-chief-executive-officer/ 2010-03-24T20:47:46+00:00 monthly 0.2 http://www.rivervest.com/urology-study-shows-reduced-side-effects-from-radiation-for-prostate-cancer-with-calypso-medical%e2%80%99s-tumor-tracking-technology/ 2010-03-09T17:15:10+00:00 monthly 0.2 http://www.rivervest.com/excaliard-initiates-phase-2-trials-in-u-s-for-its-skin-scarring-drug-exc-001/ 2010-01-25T16:58:52+00:00 monthly 0.2 http://www.rivervest.com/cydex-pharmaceuticals-receives-a-key-u-s-patent-for-composition-of-matter-and-process-of-manufacturing-high-purity-captisol%c2%ae/ 2010-01-25T16:47:27+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-closes-2009-with-positive-outlook/ 2010-01-05T15:23:58+00:00 monthly 0.2 http://www.rivervest.com/tryton-announces-registry-evaluating-tryton-stent-system-for-left-main-disease-and-celebrates-500th-implant/ 2010-01-05T15:14:19+00:00 monthly 0.2 http://www.rivervest.com/idev-technologies-names-christopher-m-owens-president-chief-executive-officer/ 2009-11-19T15:49:15+00:00 monthly 0.2 http://www.rivervest.com/cydex-pharmaceuticals-adds-industry-veteran-to-accelerate-product-commercialization-initiatives/ 2009-10-26T15:30:22+00:00 monthly 0.2 http://www.rivervest.com/lutonix-inc-announces-first-patient-enrollments-in-three-separate-clinical-trials/ 2009-10-26T14:48:22+00:00 monthly 0.2 http://www.rivervest.com/xoft-expands-cancer-treatment-platform-with-launch-of-skin-cancer-electronic-brachytherapy-trial-at-aapm-meeting/ 2009-10-26T14:19:02+00:00 monthly 0.2 http://www.rivervest.com/luminous-medical-inc-secures-exclusive-rights-to-glucose-sensor-for-its-automated-glucose-monitor/ 2009-10-26T13:57:13+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-announces-16-5m-in-new-capital-financing/ 2009-10-06T12:55:46+00:00 monthly 0.2 http://www.rivervest.com/fda-accepts-cydex-pharmaceuticals%e2%80%99-ind-application-for-oncology-drug/ 2009-10-02T15:06:58+00:00 monthly 0.2 http://www.rivervest.com/calypso-medical-closes-50-million-venture-financing-round/ 2009-10-02T15:06:06+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-inc-announces-endotech-spa-as-exclusive-distributor-for-the-verifynow-system-in-italy/ 2009-09-17T19:54:22+00:00 monthly 0.2 http://www.rivervest.com/mpex-pharmaceuticals-announces-positive-phase-2b-clinical-trial-results-with-aeroquin%c2%ae-mp-376-treatment-in-cystic-fibrosis-patients/ 2009-09-17T14:16:00+00:00 monthly 0.2 http://www.rivervest.com/paulo-f-costa-joins-macrogenics-board-of-directors/ 2009-08-04T16:03:55+00:00 monthly 0.2 http://www.rivervest.com/macrogenics-and-lilly-achieve-targeted-patient-enrollment-in-protege-a-global-phase-23-clinical-trial-of-teplizumab-in-type-1-diabetes/ 2009-08-04T15:56:05+00:00 monthly 0.2 http://www.rivervest.com/accumetrics%e2%80%99-verifynow%c2%ae-p2y12-test-provides-physicians-with-information-to-assess-a-patient%e2%80%99s-response-to-newly-approved-prasugrel-effient%c2%ae/ 2009-08-03T20:33:38+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-inc-announces-gravitas-trial-50-percent-enrolled/ 2009-08-03T20:16:53+00:00 monthly 0.2 http://www.rivervest.com/published-studies-highlight-calypso-medicals-role-in-enabling-real-time-adaptive-radiation-delivery-to-moving-tumors/ 2009-08-03T19:49:21+00:00 monthly 0.2 http://www.rivervest.com/gregory-j-tibbitts-appointed-chief-financial-officer-at-accumetrics-inc/ 2009-05-19T15:58:55+00:00 monthly 0.2 http://www.rivervest.com/calypso%c2%ae-medicals-customers-obtain-reimbursement-for-intrafraction-tracking-and-beacon%c2%ae-transponders/ 2009-05-19T15:48:51+00:00 monthly 0.2 http://www.rivervest.com/fda-clears-new-skin-and-surface-treatment-applicator-for-use-with-xofts-axxent%c2%ae-electronic-brachytherapy-ebx-system/ 2009-05-19T15:30:12+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-inc-announces-united-kingdom-distribution-agreement-with-elitech-uk-limited/ 2009-05-19T14:21:23+00:00 monthly 0.2 http://www.rivervest.com/salient-surgical-technologies-launches-new-advanced-energy-device-designed-to-improve-patient-outcomes-in-spine-surgery/ 2009-05-18T20:28:03+00:00 monthly 0.2 http://www.rivervest.com/us-food-and-drug-administration-clears-way-for-multicenter-clinical-trial-of-idev-technologies-supera-peripheral-stent/ 2009-05-18T19:53:37+00:00 monthly 0.2 http://www.rivervest.com/cydex-pharmaceuticals-presents-phase-2-clinical-trial-results-for-captisol-enabled%c2%ae-budesonideazelastine-combination-solution-nasal-spray-at-american-academy-of-allergy-asthma-and-immunology-aa/ 2009-05-18T19:10:43+00:00 monthly 0.2 http://www.rivervest.com/fda-clears-new-skin-and-surface-treatment-applicator-for-use-with-xofts-axxent%c2%ae-electronic-brachytherapy-cbx-system/ 2009-03-17T16:53:27+00:00 monthly 0.2 http://www.rivervest.com/duke-university-medical-center-optimizes-radiation-treatment-targeting-and-efficiency-with-calypso%c2%ae-4d-localization-system%e2%84%a2/ 2009-02-25T21:34:59+00:00 monthly 0.2 http://www.rivervest.com/salient-surgical-technologies-elects-bobby-i-griffin-to-board-of-directors/ 2009-02-25T21:32:30+00:00 monthly 0.2 http://www.rivervest.com/cydex-pharmaceuticals-announces-captisol%c2%ae-technology-used-in-recently-approved-cosolvent-free-formulation-of-amiodarone-iv/ 2009-02-25T20:41:48+00:00 monthly 0.2 http://www.rivervest.com/cydex-pharmaceuticals-receives-orphan-drug-designation-for-melphalan/ 2009-02-25T19:04:19+00:00 monthly 0.2 http://www.rivervest.com/team/william-a-peck/ 2009-02-25T16:27:47+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/william-a-peck/ 2009-02-25T16:27:22+00:00 weekly 0.6 http://www.rivervest.com/team/nancy-j-hutson/ 2009-02-25T16:21:50+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/nancy-j-hutson/ 2009-02-25T16:21:01+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/joseph-m-davie/ 2009-02-25T16:19:54+00:00 weekly 0.6 http://www.rivervest.com/team/joseph-m-davie/ 2009-02-25T16:18:59+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/michael-berman/ 2009-02-25T16:16:07+00:00 weekly 0.6 http://www.rivervest.com/team/michael-berman/ 2009-02-25T16:15:17+00:00 weekly 0.6 http://www.rivervest.com/team/floyd-e-bloom/ 2009-02-25T16:11:24+00:00 weekly 0.6 http://www.rivervest.com/mobile/team-2/floyd-e-bloom/ 2009-02-25T16:08:36+00:00 weekly 0.6 http://www.rivervest.com/mpex-pharmaceuticals-announces-series-d-financing-of-up-to-40-million/ 2009-02-24T21:19:02+00:00 monthly 0.2 http://www.rivervest.com/lutonix-inc-announces-20-million-series-b-financing/ 2009-02-24T21:17:04+00:00 monthly 0.2 http://www.rivervest.com/tryton-medical-announces-two-key-hires-and-relocation-to-research-triangle-park-nc/ 2009-01-08T17:52:29+00:00 monthly 0.2 http://www.rivervest.com/contact-us/ 2008-10-18T19:33:15+00:00 weekly 0.6 http://www.rivervest.com/rivervest-venture-partners%e2%84%a2-closes-on-fund-i-former-nationsbank-chairman-andy-craig-and-former-head-of-federal-reserve-bank-of-st-louis-tom-melzer-are-among-founders/ 2008-10-18T19:26:11+00:00 monthly 0.2 http://www.rivervest.com/rivervest-venture-partners%c2%ae-names-new-associate-and-scientific-advisor/ 2008-10-18T19:25:36+00:00 monthly 0.2 http://www.rivervest.com/rivervest-venture-partners-names-dennis-wahr-md-managing-director/ 2008-10-18T19:24:39+00:00 monthly 0.2 http://www.rivervest.com/rivervest-venture-partners-names-gordon-foulkes-phd-venture-partner-promotes-scott-naisbitt-md-phd-to-principal/ 2008-10-18T19:23:58+00:00 monthly 0.2 http://www.rivervest.com/lilly-and-macrogenics-announce-licensing-and-collaboration-agreement/ 2008-10-18T19:23:00+00:00 monthly 0.2 http://www.rivervest.com/calypso%c2%ae-medical-and-impac-medical-systems-to-develop-motion-management-solutions/ 2008-10-18T19:22:38+00:00 monthly 0.2 http://www.rivervest.com/isis-and-excaliard-collaborate-to-develop-antisense-drugs-for-local-treatment-of-fibrotic-diseases/ 2008-10-18T19:22:07+00:00 monthly 0.2 http://www.rivervest.com/cleveland-office-opening/ 2008-10-18T19:21:41+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-announces-288-million-financing-and-initiation-of-pivotal-clinical-trial/ 2008-10-18T19:21:14+00:00 monthly 0.2 http://www.rivervest.com/tissuelink-medical-changes-name-to-salient-surgical-technologies/ 2008-10-18T19:20:39+00:00 monthly 0.2 http://www.rivervest.com/tryton-medical-inc-closes-14-million-financing/ 2008-10-18T19:20:05+00:00 monthly 0.2 http://www.rivervest.com/rivervest-venture-partners%c2%ae-a-st-louis-based-venture-capital-firm-focusing-on-life-sciences-closes-on-fund-ii-names-john-p-mckearn-phd-venture-partner/ 2008-10-18T19:19:44+00:00 monthly 0.2 http://www.rivervest.com/j-greg-davis-appointed-president-chief-executive/ 2008-10-18T19:19:24+00:00 monthly 0.2 http://www.rivervest.com/fda-clears-calyso%c2%ae-medicals-gps-for-the-body%c2%ae/ 2008-10-18T19:18:33+00:00 monthly 0.2 http://www.rivervest.com/macrogenics-appoints-new-chief-commercial-officer-and-chief-financial-officer/ 2008-10-18T19:18:02+00:00 monthly 0.2 http://www.rivervest.com/fda-clears-new-applicators-for-endometrial-cancer-treatment-with-xofts-axxent%c2%ae-electronic-brachytherapy-system/ 2008-10-18T19:17:33+00:00 monthly 0.2 http://www.rivervest.com/accumetrics-announces-the-launch-and-first-patient-enrolled-into-the-gravitas-trial/ 2008-10-18T19:17:07+00:00 monthly 0.2 http://www.rivervest.com/calypso%c2%ae-medical%e2%80%99s-eric-r-meier-named-ernst-young-entrepreneur-of-the-year%c2%ae-2008-pacific-northwest-winner-in-the-health-care-life-sciences-category/ 2008-10-18T19:15:40+00:00 monthly 0.2 http://www.rivervest.com/first-breast-cancer-patient-receives-treatment-in-national-electronic-brachytherapy-registry-launched-by-three-physician-societies/ 2008-10-18T19:15:00+00:00 monthly 0.2 http://www.rivervest.com/macrogenics-acquires-raven-biotechnologies/ 2008-10-18T19:14:41+00:00 monthly 0.2 http://www.rivervest.com/centerre-expands-development-team/ 2008-10-18T19:14:20+00:00 monthly 0.2 http://www.rivervest.com/calypso%c2%ae-medical-technologies-reports-advancements-in-radiation-treatment-for-cancer-patients/ 2008-10-18T19:13:58+00:00 monthly 0.2 http://www.rivervest.com/xoft-secures-25-million-in-additional-funding-for-award-winning-electronic-brachytherapy-technology/ 2008-10-18T19:13:33+00:00 monthly 0.2 http://www.rivervest.com/calypso-medical-and-siemens-announce-innovative-product-development-collaboration-agreement/ 2008-10-18T19:12:51+00:00 monthly 0.2 http://www.rivervest.com/macrogenics-raises-25m-in-series-d-2-financing/ 2008-10-18T19:12:36+00:00 monthly 0.2 http://www.rivervest.com/excaliard-pharmaceuticals-appoints-lincoln-krochmal-md-president-chief-executive-officer-and-jeffrey-jensen-head-of-clinical-operations/ 2008-10-18T19:12:15+00:00 monthly 0.2 http://www.rivervest.com/mobile/contact-us-2/ 2008-10-18T18:47:44+00:00 weekly 0.6 http://www.rivervest.com/home/home-page-case-study-2/ 2008-10-18T18:21:55+00:00 weekly 0.6 http://www.rivervest.com/mobile/ 2008-10-18T18:18:52+00:00 weekly 0.6 http://www.rivervest.com/news/ 2008-10-01T03:06:06+00:00 weekly 0.6